Comparison of patient knowledge, treatment utilisation and severity of hidradenitis suppurativa following dermatology nurse education program: A randomised cross-over study
Not Applicable
Not yet recruiting
- Conditions
- Hidradenitis suppurativa
- Registration Number
- ACTRN12618001504202
- Lead Sponsor
- Dr Bradley Miller
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie hidradenitis suppurativa pathogenesis and how might nurse-led education impact these pathways?
How does dermatology nurse education compare to standard care in improving hidradenitis suppuratis treatment adherence and clinical outcomes?
Are there specific biomarkers that correlate with hidradenitis suppurativa severity and response to non-pharmacological interventions like nurse education?
What adverse events are commonly associated with hidradenitis suppurativa management and how does nurse education influence their mitigation?
What combination therapies or novel compounds show promise in hidradenitis suppurativa treatment compared to educational interventions alone?